Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

William Edward Boden, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Lyubarova R, Albers JJ, Marcovina SM, Yao Y, McBride R, Topliceanu A, Anderson T, Fleg JL, Desvigne-Nickens P, Kashyap ML, McGovern ME, Boden WE. Effects of Extended-Release Niacin on Quartile Lp-PLA2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial. J Cardiovasc Pharmacol Ther. 2019 May 26; 1074248419852955. PMID: 31131629.
    Citations:    
  2. Koutroumpakis E, Gosmanova EO, Stahura H, Jou S, Alreshq R, Ata A, Sidhu MS, Philbin E, Boden WE, Lyubarova R. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease. Cardiovasc Drugs Ther. 2019 May 23. PMID: 31123935.
    Citations:    
  3. Mancini GBJ, Maron DJ, Hartigan PM, Spertus JA, Kostuk WJ, Berman DS, Teo KK, Weintraub WS, Boden WE. Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes. J Am Coll Cardiol. 2019 Apr 30; 73(16):2049-2058. PMID: 31023428.
    Citations:    
  4. Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Alexander KP, Senior R, Boden WE, Stone GW, Goodman SG, Lopes RD, Lopez-Sendon J, White HD, Maggioni AP, Shaw LJ, Min JK, Picard MH, Berman DS, Chaitman BR, Mark DB, Spertus JA, Cyr DD, Bhargava B, Ruzyllo W, Wander GS, Chernyavskiy AM, Rosenberg YD, Maron DJ. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. JAMA Cardiol. 2019 Feb 27. PMID: 30810700.
    Citations:    
  5. Rasalingam R, Boden WE. Role of Ranolazine in Reducing Angina, Subsequent Revascularization, and Healthcare Expenditures in Stable Ischemic Heart Disease. Am J Cardiol. 2019 May 15; 123(10):1729-1731. PMID: 30922541.
    Citations:    
  6. Farkouh ME, Sidhu MS, Brooks MM, Vlachos H, Boden WE, Frye RL, Hartigan P, Siami FS, Bittner VA, Chaitman BR, Mancini GBJ, Fuster V. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes. J Am Coll Cardiol. 2019 Feb 05; 73(4):400-411. PMID: 30704571.
    Citations:    Fields:    
  7. Weintraub WS, Hartigan PM, Mancini GBJ, Teo KK, Maron DJ, Spertus JA, Chaitman BR, Shaw LJ, Berman D, Boden WE. Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease. Circ Cardiovasc Qual Outcomes. 2019 Feb; 12(2):e005079. PMID: 30773025.
    Citations:    
  8. Wadhera RK, Sukul D, Secemsky EA, Shen C, Gurm HS, Boden WE, Yeh RW. Temporal Trends in Unstable Angina Diagnosis Codes for Outpatient Percutaneous Coronary Interventions. JAMA Intern Med. 2019 Feb 01; 179(2):259-261. PMID: 30556822.
    Citations:    Fields:    
  9. Maron DJ, Mancini GBJ, Hartigan PM, Spertus JA, Sedlis SP, Kostuk WJ, Berman DS, Teo KK, Weintraub WS, Boden WE. Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial. J Am Coll Cardiol. 2018 Nov 06; 72(19):2297-2305. PMID: 30384885.
    Citations:    Fields:    
  10. Boden WE, Bhatt DL. Will COMPASS Point to a New Direction in Thrombotic Risk Reduction in Patients With Stable Cardiovascular Disease? Circulation. 2018 Aug 28; 138(9):858-860. PMID: 30354448.
    Citations:    Fields:    
  11. Saour BM, Wang JH, Lavelle MP, Mathew RO, Sidhu MS, Boden WE, Sacco JD, Costanzo EJ, Hossain MA, Vachharanji T, Alrefaee A, Asif A. TpTe and TpTe/QT: novel markers to predict sudden cardiac death in ESRD? J Bras Nefrol. 2019 Jan-Mar; 41(1):38-47. PMID: 30118535.
    Citations:    Fields:    
  12. Bangalore S, Maron DJ, Fleg JL, O'Brien SM, Herzog CA, Stone GW, Mark DB, Spertus JA, Alexander KP, Sidhu MS, Chertow GM, Boden WE, Hochman JS. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design. Am Heart J. 2018 11; 205:42-52. PMID: 30172098.
    Citations:    Fields:    
  13. Probstfield JL, Boden WE, Anderson T, Branch K, Kashyap M, Fleg JL, Desvigne-Nickens P, McBride R, McGovern M. Cardiovascular outcomes during extended follow-up of the AIM-HIGH trial cohort. J Clin Lipidol. 2018 Nov - Dec; 12(6):1413-1419. PMID: 30131256.
    Citations:    Fields:    
  14. Boden WE, Redberg RF. Evolving from volume to value, or to a bolder vision of reimbursement reform? Am Heart J. 2018 10; 204:174-177. PMID: 30146116.
    Citations:    Fields:    
  15. Mok Y, Ballew SH, Bash LD, Bhatt DL, Boden WE, Bonaca MP, Carrero JJ, Coresh J, D'Agostino RB, Elley CR, Fowkes FGR, Jee SH, Kovesdy CP, Mahaffey KW, Nadkarni G, Peterson ED, Sang Y, Matsushita K. International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee. J Am Heart Assoc. 2018 Jul 07; 7(14). PMID: 29982232.
    Citations:    Fields:    
  16. Weintraub WS, Taggart DP, Mancini GBJ, Brown DL, Boden WE. Historical Milestones in the Management of Stable Coronary Artery Disease over the Last Half Century. Am J Med. 2018 Nov; 131(11):1285-1292. PMID: 29959899.
    Citations:    Fields:    
  17. Ganda OP, Bhatt DL, Mason RP, Miller M, Boden WE. Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management. J Am Coll Cardiol. 2018 Jul 17; 72(3):330-343. PMID: 29935936.
    Citations: 1     Fields:    
  18. Mancini GBJ, Boden WE, Brooks MM, Vlachos H, Chaitman BR, Frye R, Bittner V, Hartigan PM, Dagenais GR. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials. Atherosclerosis. 2018 Oct; 277:186-194. PMID: 29861270.
    Citations:    Fields:    
  19. Zhang Z, Jones P, Weintraub WS, Mancini GBJ, Sedlis S, Maron DJ, Teo K, Hartigan P, Kostuk W, Berman D, Boden WE, Spertus JA. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). Circ Cardiovasc Qual Outcomes. 2018 May; 11(5):e003971. PMID: 29752388.
    Citations:    Fields:    
  20. Maron DJ, Hochman JS, O'Brien SM, Reynolds HR, Boden WE, Stone GW, Bangalore S, Spertus JA, Mark DB, Alexander KP, Shaw L, Berger JS, Ferguson TB, Williams DO, Harrington RA, Rosenberg Y. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. Am Heart J. 2018 07; 201:124-135. PMID: 29778671.
    Citations: 3     Fields:    
  21. Ramadan R, Boden WE, Kinlay S. Management of Left Main Coronary Artery Disease. J Am Heart Assoc. 2018 Mar 31; 7(7). PMID: 29605817.
    Citations:    
  22. Williams BA, Chagin KM, Bash LD, Boden WE, Duval S, Fowkes FGR, Mahaffey KW, Patel MD, D'Agostino RB, Peterson ED, Kattan MW, Bhatt DL, Bonaca MP. External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction. Atherosclerosis. 2018 05; 272:80-86. PMID: 29579671.
    Citations:    Fields:    
  23. Toth PP, Jones SR, Slee A, Fleg J, Marcovina SM, Lacy M, McBride R, Boden WE. Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial. J Clin Lipidol. 2018 May - Jun; 12(3):741-747.e11. PMID: 29627296.
    Citations:    Fields:    
  24. Otvos JD, Guyton JR, Connelly MA, Akapame S, Bittner V, Kopecky SL, Lacy M, Marcovina SM, Muhlestein JB, Boden WE. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial. J Clin Lipidol. 2018 Mar - Apr; 12(2):348-355.e2. PMID: 29409728.
    Citations:    Fields:    
  25. Lyubarova R, Boden WE, Fein SA, Schulman-Marcus J, Torosoff M. Successful percutaneous coronary intervention significantly improves coronary sinus blood flow as assessed by transthoracic echocardiography. J Echocardiogr. 2018 06; 16(2):65-71. PMID: 29116574.
    Citations:    Fields:    
  26. Schulman-Marcus J, Boden WE. Early Revascularization in NSTE-ACS: Insights From the ICTUS Long-Term Follow-Up. J Am Coll Cardiol. 2017 09 12; 70(11):1423-1424. PMID: 28882243.
    Citations:    Fields:    
  27. Weintraub WS, Boden WE. Making Cardiovascular Care More Responsive to Societal Needs. Am J Med. 2017 11; 130(11):1259-1261. PMID: 28797644.
    Citations:    Fields:    Translation:Humans
  28. Schulman-Marcus J, Weintraub WS, Boden WE. Reconsidering the Gatekeeper Paradigm for Percutaneous Coronary Intervention in Stable Coronary Disease Management. Am J Cardiol. 2017 Oct 15; 120(8):1450-1452. PMID: 28818317.
    Citations: 1     Fields:    Translation:Humans
  29. Lyubarova R, Robinson JG, Miller M, Simmons DL, Xu P, Abramson BL, Elam MB, Brown TM, McBride R, Fleg JL, Desvigne-Nickens P, Ayenew W, Boden WE. Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial. J Clin Lipidol. 2017 Sep - Oct; 11(5):1201-1211. PMID: 28807460.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  30. Banerjee S, Angiolillo DJ, Boden WE, Murphy JG, Khalili H, Hasan AA, Harrington RA, Rao SV. Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery. J Am Coll Cardiol. 2017 Apr 11; 69(14):1861-1870. PMID: 28385315.
    Citations: 2     Fields:    Translation:Humans
  31. Padala SK, Lavelle MP, Sidhu MS, Cabral KP, Morrone D, Boden WE, Toth PP. Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review. J Cardiovasc Pharmacol Ther. 2017 Nov; 22(6):499-510. PMID: 28361599.
    Citations:    Fields:    Translation:HumansAnimals
  32. Boden WE, Meadows JL. Role of Imaging in the Management of Stable Ischemic Heart Disease: An Evolving Paradigm Shift. JACC Cardiovasc Imaging. 2017 03; 10(3):335-337. PMID: 28279381.
    Citations: 1     Fields:    Translation:Humans
  33. Pragani MA, Desai KP, Morrone D, Sidhu MS, Boden WE. The Role of Nitrates in the Management of Stable Ischemic Heart Disease: A Review of the Current Evidence and Guidelines. Rev Cardiovasc Med. 2017; 18(1):14-20. PMID: 28509889.
    Citations: 1     Fields:    
  34. Mathew RO, Bangalore S, Lavelle MP, Pellikka PA, Sidhu MS, Boden WE, Asif A. Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review. Kidney Int. 2017 04; 91(4):797-807. PMID: 28040264.
    Citations: 4     Fields:    Translation:HumansAnimals
  35. Mancini GB, Farkouh ME, Brooks MM, Chaitman BR, Boden WE, Vlachos H, Hartigan PM, Siami FS, Sidhu MS, Bittner V, Frye R, Fuster V. Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease. J Am Coll Cardiol. 2016 09 06; 68(10):985-95. PMID: 27585501.
    Citations: 6     Fields:    Translation:Humans
  36. Nappi AG, Boden WE. Should Beta-Blockers Continue to Be Used in Post-Percutaneous Coronary Intervention Patients Without Myocardial Infarction? JACC Cardiovasc Interv. 2016 08 22; 9(16):1649-51. PMID: 27539684.
    Citations:    Fields:    Translation:Humans
  37. Weintraub WS, Boden WE. Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease. JAMA Intern Med. 2016 08 01; 176(8):1190-4. PMID: 27380178.
    Citations: 2     Fields:    Translation:Humans
  38. Wijeysundera HC, Sidhu MS, Bennell MC, Qiu F, Ko DT, Knudtson ML, Tu JV, Boden WE. Predictors of Initial Revascularization Versus Medical Therapy Alone in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing an Invasive Strategy. Circ Cardiovasc Interv. 2016 07; 9(7). PMID: 27418612.
    Citations:    Fields:    Translation:Humans
  39. Mody P, Sidhu MS, Brilakis ES, Sacco JD, Banerjee S, Boden WE. Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review. Cardiol Rev. 2016 Jul-Aug; 24(4):177-89. PMID: 26274534.
    Citations:    Fields:    Translation:Humans
  40. Asleh R, Levy NS, Doros G, Costacou T, Robinson JG, Blum S, Goldenstein H, Boden WE, Simmons DL, Lacy MA, Grunberger G, Anderson TJ, Levy AP. Haptoglobin Genotype as a Determinant of Benefit or Harm From Niacin for Participants With Diabetes. J Am Coll Cardiol. 2016 05 31; 67(21):2553-4. PMID: 27230052.
    Citations: 1     Fields:    Translation:Humans
  41. Hagström E, Roe MT, Hafley G, Neely ML, Sidhu MS, Winters KJ, Prabhakaran D, White HD, Armstrong PW, Fox KA, Ohman EM, Boden WE. Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial. Clin Cardiol. 2016 Jun; 39(6):329-37. PMID: 27177240.
    Citations:    Fields:    Translation:HumansCells
  42. Schulman-Marcus J, Boden WE. A PROMISE Fulfilled That Quality-of-Life Assessments Afford Incremental Value to Coronary Artery Disease Management. Circulation. 2016 May 24; 133(21):1989-91. PMID: 27143677.
    Citations:    Fields:    Translation:Humans
  43. Kaul P, Ohman EM, Knight JD, Anstrom KJ, Roe MT, Boden WE, Hochman JS, Gašparovic V, Armstrong PW, McCollam P, Fakhouri W, Cowper P, Davidson-Ray L, Clapp-Channing N, White HD, Fox KA, Prabhakaran D, Mark DB. Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial. Am Heart J. 2016 Aug; 178:55-64. PMID: 27502852.
    Citations:    Fields:    Translation:Humans
  44. Nappi AG, Boden WE. Does Physiology Trump Anatomy as the "Best Course" to Guide PCI Decision Making and Outcomes? J Am Coll Cardiol. 2016 Apr 12; 67(14):1712-4. PMID: 27056777.
    Citations:    Fields:    Translation:Humans
  45. Chin CT, Boden WE, Roe MT, Neely B, Neely ML, Leiva-Pons JL, Corbalán R, Gottlieb S, Dalby AJ, Armstrong PW, Prabhakaran D, Fox KA, White HD, Ohman EM, Winters KJ, Schiele F. Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients. Heart. 2016 08 01; 102(15):1221-9. PMID: 27030601.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  46. Goldberg RB, Bittner VA, Dunbar RL, Fleg JL, Grunberger G, Guyton JR, Leiter LA, McBride R, Robinson JG, Simmons DL, Wysham C, Xu P, Boden WE. Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH. Am J Med. 2016 Jul; 129(7):753.e13-22. PMID: 27036394.
    Citations: 1     Fields:    Translation:Humans
  47. Boden WE. A Novel Diagnostic Approach for Evaluating Suspected Coronary Artery Disease. Am J Med. 2016 Jun; 129(6):557-9. PMID: 26836388.
    Citations:    Fields:    Translation:Humans
  48. Boden WE, Mancini GB. CABG for Complex CAD: When Will Evidence-Based Practice Align With Evidence-Based Medicine? J Am Coll Cardiol. 2016 Jan 05; 67(1):56-8. PMID: 26764066.
    Citations: 2     Fields:    Translation:Humans
  49. Cheng-Torres KA, Desai KP, Sidhu MS, Maron DJ, Boden WE. Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial? Future Cardiol. 2016 Jan; 12(1):35-44. PMID: 26696561.
    Citations:    Fields:    Translation:Humans
  50. Stone GW, Hochman JS, Williams DO, Boden WE, Ferguson TB, Harrington RA, Maron DJ. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise. J Am Coll Cardiol. 2016 Jan 05; 67(1):81-99. PMID: 26616030.
    Citations: 9     Fields:    Translation:Humans
  51. Sedlis SP, Hartigan PM, Teo KK, Maron DJ, Spertus JA, Mancini GB, Kostuk W, Chaitman BR, Berman D, Lorin JD, Dada M, Weintraub WS, Boden WE. Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. N Engl J Med. 2015 Nov 12; 373(20):1937-46. PMID: 26559572.
    Citations: 20     Fields:    Translation:Humans
  52. Torosoff MT, Sidhu MS, Desai KP, Fein SA, Boden WE. Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize. J Comp Eff Res. 2015 Sep; 4(5):505-14. PMID: 26387530.
    Citations:    Fields:    Translation:Humans
  53. Boden WE. MY APPROACH to managing stable ischemic heart disease. Trends Cardiovasc Med. 2015 Nov; 25(8):753-4. PMID: 26410543.
    Citations:    Fields:    Translation:Humans
  54. Padala SK, Sidhu MS, Hartigan PM, Maron DJ, Teo KK, Spertus JA, Mancini GB, Sedlis SP, Chaitman BR, Heller GV, Weintraub WS, Boden WE. Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial). Am J Cardiol. 2015 Nov 15; 116(10):1509-15. PMID: 26410604.
    Citations:    Fields:    Translation:Humans
  55. Boden WE, Padala SK, Cabral KP, Buschmann IR, Sidhu MS. Role of short-acting nitroglycerin in the management of ischemic heart disease. Drug Des Devel Ther. 2015; 9:4793-805. PMID: 26316714.
    Citations: 4     Fields:    Translation:HumansAnimals
  56. Maron DJ, Boden WE. Why Optimal Medical Therapy Should Be a Universal Standard of Care. J Am Coll Cardiol. 2015 Aug 18; 66(7):774-776. PMID: 26271058.
    Citations:    Fields:    Translation:Humans
  57. Acharjee S, Teo KK, Jacobs AK, Hartigan PM, Barn K, Gosselin G, Tanguay JF, Maron DJ, Kostuk WJ, Chaitman BR, Mancini GB, Spertus JA, Dada MR, Bates ER, Booth DC, Weintraub WS, O'Rourke RA, Boden WE. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. Am Heart J. 2016 Mar; 173:108-17. PMID: 26920603.
    Citations: 2     Fields:    Translation:Humans
  58. Dhamija RK, Tan H, Philbin E, Mathew RO, Sidhu MS, Wang J, Saour B, Haqqie SS, Beathard G, Yevzlin AS, Salman L, Boden WE, Siskin G, Asif A. Subcutaneous implantable cardioverter defibrillator for dialysis patients: a strategy to reduce central vein stenoses and infections. Am J Kidney Dis. 2015 Jul; 66(1):154-8. PMID: 25911316.
    Citations: 4     Fields:    Translation:Humans
  59. Bradley SM, Chan PS, Hartigan PM, Nallamothu BK, Weintraub WS, Sedlis SP, Dada M, Maron DJ, Kostuk WJ, Berman DS, Teo KK, Mancini GB, Boden WE, Spertus JA. Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial). Am J Cardiol. 2015 Jul 15; 116(2):167-73. PMID: 25960375.
    Citations:    Fields:    Translation:Humans
  60. Sidhu MS, Boden WE. The continued importance of optimal medical therapy with or without revascularization in diabetic patients with coronary artery disease. Trends Cardiovasc Med. 2015 Oct; 25(7):632-4. PMID: 25957809.
    Citations:    Fields:    Translation:Humans
  61. Kalil RS, Wang JH, de Boer IH, Mathew RO, Ix JH, Asif A, Shi X, Boden WE. Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial. Kidney Int. 2015 Jun; 87(6):1250-7. PMID: 25651367.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  62. Toth PP, Murthy AM, Sidhu MS, Boden WE. Is HPS2-THRIVE the death knell for niacin? J Clin Lipidol. 2015 May-Jun; 9(3):343-50. PMID: 26073392.
    Citations: 1     Fields:    Translation:Humans
  63. Bangalore S, Bhatt DL, Steg PG, Weber MA, Boden WE, Hamm CW, Montalescot G, Hsu A, Fox KA, Lincoff AM. ß-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial. Circ Cardiovasc Qual Outcomes. 2014 Nov; 7(6):872-81. PMID: 25271049.
    Citations: 9     Fields:    Translation:Humans
  64. Desai KP, Sidhu MS, Boden WE. Evaluation of the stable coronary artery disease patient: anatomy trumps physiology. Trends Cardiovasc Med. 2014 Nov; 24(8):332-40. PMID: 25241252.
    Citations:    Fields:    Translation:Humans
  65. Anderson TJ, Boden WE, Desvigne-Nickens P, Fleg JL, Kashyap ML, McBride R, Probstfield JL. Safety profile of extended-release niacin in the AIM-HIGH trial. N Engl J Med. 2014 Jul 17; 371(3):288-90. PMID: 25014706.
    Citations: 10     Fields:    Translation:Humans
  66. Soukoulis V, Boden WE, Smith SC, O'Gara PT. Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon. Circ Res. 2014 Jun 06; 114(12):1944-58. PMID: 24902977.
    Citations: 5     Fields:    Translation:Humans
  67. Shaw LJ, Berman DS, Picard MH, Friedrich MG, Kwong RY, Stone GW, Senior R, Min JK, Hachamovitch R, Scherrer-Crosbie M, Mieres JH, Marwick TH, Phillips LM, Chaudhry FA, Pellikka PA, Slomka P, Arai AE, Iskandrian AE, Bateman TM, Heller GV, Miller TD, Nagel E, Goyal A, Borges-Neto S, Boden WE, Reynolds HR, Hochman JS, Maron DJ, Douglas PS. Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC Cardiovasc Imaging. 2014 Jun; 7(6):593-604. PMID: 24925328.
    Citations: 23     Fields:    Translation:Humans
  68. Boden WE, Franklin B, Berra K, Haskell WL, Calfas KJ, Zimmerman FH, Wenger NK. Exercise as a therapeutic intervention in patients with stable ischemic heart disease: an underfilled prescription. Am J Med. 2014 Oct; 127(10):905-11. PMID: 24844736.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  69. Tariq SM, Sidhu MS, Toth PP, Boden WE. HDL hypothesis: where do we stand now? Curr Atheroscler Rep. 2014 Apr; 16(4):398. PMID: 24619460.
    Citations: 9